Published in Lancet on April 06, 1985
Blood transfusions and cancer: anomalies explained? Br Med J (Clin Res Ed) (1986) 0.78
Aetiology of Kaposi's sarcoma. Lancet (1990) 1.95
Tissue- and species-specific antigens of normal human prostatic tissue. J Immunol (1970) 1.22
The effect of estrogen on the incorporation of 3H-thymidine by PHA-stimulated human peripheral blood lymphocytes. J Immunol (1974) 1.21
Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations. J Urol (1970) 1.18
Thymus-specific antigens on human thymocytes and on thymic-derived lymphocytes. Transplantation (1973) 1.10
Immunologic studies of normal, benign, and malignant human prostatic tissue. Cancer (1972) 1.09
IgE in pemphigus. Arch Dermatol (1977) 1.09
Precipitating antigens of the normal human prostate. J Reprod Fertil (1970) 1.04
Pemphigus-like antibodies in patients with skin burns. Vox Sang (1969) 1.02
Precipitating antibody in the sera of patients treated cryosurgically for carcinoma of the prostate. Exp Med Surg (1969) 0.98
Serum proteins in patients with benign and malignant diseases of the prostate. Neoplasma (1971) 0.97
Blood product immunosuppression and the acquired immunodeficiency syndrome. Ann Intern Med (1986) 0.97
Alterations of alpha2-globulin and the clinical response in patients with prostatic cancer following cryotherapy. Oncology (1975) 0.91
Localization of immunoglobulins in human prostatic tissue. J Immunol (1971) 0.90
Tissue- and species-specific antibodies in antithymocyte globulin. Transplantation (1972) 0.90
Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate. Cancer Res (1978) 0.89
Hormonal therapy and alteration of lymphocyte proliferation. J Lab Clin Med (1976) 0.89
Immunobiology of the Dunning R-3327 rat prostate adenocarcinoma sublines: plasma and tumor effusion prostaglandins. Am J Reprod Immunol Microbiol (1985) 0.87
The female prostate and prostate-specific antigen. Immunohistochemical localization, implications of this prostate marker in women and reasons for using the term "prostate" in the human female. Histol Histopathol (2000) 0.87
Immunochemical characterization of epithelial antigen(s) reactive with pemphigus-like antibodies of rabbit and human pemphigus autoantibodies. J Hyg Epidemiol Microbiol Immunol (1969) 0.87
Condylomata acuminata: treatment by autogenous vaccine. IMJ Ill Med J (1975) 0.87
Cancer, immunological surveillance, and 2 -globulin. Lancet (1972) 0.86
Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. I. Identification of anti-tumour cell-mediated immunity and "blocking" factor. Eur J Cancer (1977) 0.85
Lipofuscin granules in normal, benign and malignant human prostatic tissue. Urol Res (1973) 0.84
Immunopathologic studies of experimental pemphigus-like autoantibodies and bullous-like lesions. J Invest Dermatol (1969) 0.83
Adjuvant immunotherapy (BCG) in stage D prostate cancer. Am J Clin Oncol (1982) 0.82
In vivo bound immunoglobulins in the human prostate--their identification and possible significance. Z Immunitatsforsch Exp Klin Immunol (1972) 0.82
A retrospective look at studies on prostate-specific antigen. Clin Chem (1985) 0.82
Immunosuppression of cell- and serum-medicated tumour-associated immunity in prostatic cancer by human seminal plasma. Eur J Cancer (1980) 0.82
Prostaglandin modulation of prostate tumor growth and metastases. Anticancer Res (1986) 0.82
A tissue type transglutaminase in human seminal plasma. Am J Reprod Immunol (1997) 0.82
Autoallergy in pemphigus. Lancet (1968) 0.81
Letter: Antiepithelial antibodies: a possible clue to malignant neoplasms. Arch Dermatol (1974) 0.81
Fibrinolysis resistant fibrin deposits in lymph nodes with Hodgkin's disease. Thromb Haemost (1988) 0.81
Cryosurgery of the rabbit prostate. Comparison of the immune response of immature and mature bucks. Cryobiology (1974) 0.81
Immunologic sequelae of thermal injury. I. Frequency and relationship of epithelial antibodies to extent of burn. Clin Immunol Immunopathol (1976) 0.81
Fluorescent studies of antibodies to rabbit male urogenital tissue. Experientia (1969) 0.81
Antiepithelial antibodies in the serum of patients with benign and malignant diseases of the prostate. Z Immunitatsforsch Exp Klin Immunol (1973) 0.81
Freezing of the esophagus: histological changes and immunological response. Int Surg (1982) 0.81
Suppression of tumor-associated immunity by human seminal plasma and its possible role in the natural history of prostatic cancer. Eur Urol (1980) 0.80
Carcinoembryonic antigen in the diagnosis of prostate carcinoma. Oncology (1974) 0.80
Absorption studies on antigen(s) of the esophageal mucosa reactive with autoantibodies of pemphigus. Int Arch Allergy Appl Immunol (1968) 0.80
Selective deficiency of IgA. Lancet (1971) 0.79
Elution of in vivo bound antiprostatic epithelial antibodies following multiple cryotherapy of carcinoma of prostate. Urology (1973) 0.79
Anti-tissue IgG antibodies and deficiency of IgA. Vox Sang (1972) 0.79
Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. III. Inhibition of leucocyte migration. Urol Int (1976) 0.79
Immunotherapy for prostatic cancer. Previous and prospective considerations. Oncology (1975) 0.79
Androgens and oestrogens may modulate the growth and function of lymphoid organs. J Immunol (1984) 0.79
Modulatory effects of oestrogen on immunological responsiveness. II. Suppression of tumour-associated immunity in patients with prostatic cancer. Clin Exp Immunol (1979) 0.79
Modulatory effects of estrogen on immunologic responsiveness. III. Effect of hormonal versus nonhormonal therapy on tumor-associated immunity in prostatic cancer. Am J Reprod Immunol (1981) 0.79
Immunologic responsiveness & tumour growth of the Dunning R3327 rat prostatic adenocarcinoma following cryosurgery & orchiectomy. Indian J Exp Biol (1982) 0.78
Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. II. Tissue- and disease-specificity of antitumour cell-mediated immunity. Eur J Cancer (1979) 0.78
Tumor-associated immunity in prostatic cancer as evaluated by tube antigen-induced leukocyte adherence inhibition: reactivity and specificity of responsiveness, and relationship to stage, grade and therapy. J Reticuloendothel Soc (1979) 0.78
The normal female and the male breast epithelium does not express prostate-specific antigen. Preliminary immunohistochemical observations of autopsy breast tissues. Gen Physiol Biophys (1999) 0.78
Immunologic studies of patients with pulmonary emphysema. Ann Allergy (1973) 0.78
Cellular immunity in bladder cancer patients. J Urol (1978) 0.78
Immunofluorescent identification of a human thymic specific antigen. Blut (1974) 0.78
Cell-mediated immunity in prostatic cancer. Clin Oncol (1980) 0.78
HIV-related protein in the prostate: a possible reservoir of virus. Am J Clin Pathol (1991) 0.78
Carcinoembryonic-like antigen in the urine of patients with carcinoma of the bladder and normal controls. J Surg Oncol (1974) 0.78
Urinary carcinoembryonic-like antigen levels in patients with bladder carcinoma. J Urol (1974) 0.78
Immunologic aspects of malignancy. II. Host immunocompetence and relationship to the clinical stage in patients with prostatic cancer. Allergol Immunopathol (Madr) (1976) 0.78
Immunosuppressive effect of estrogen on thymic dependent lymphocytic blastogenesis. Urol Res (1974) 0.78
Experimental concurrence of pemphigus-like autoantibodies and bullous-like lesions. A preliminary report. Jpn J Med Sci Biol (1969) 0.78
Hormonal epidemiology of prostatic cancer. Med J Aust (1977) 0.77
A possible immuno-cryothermic response in prostatic cancer. Clin Radiol (1970) 0.77
Immunologic studies of the prostate. A review. Int Surg (1969) 0.77
Sperm-induced urolithiasis in the rat. Eur J Epidemiol (1994) 0.77
Cryoimmunotherapy. Br Med J (1972) 0.77
Cytotoxic antibodies to allogenic lymphocytes in prostatic cancer. JAMA (1972) 0.77
Impotence therapy and cancer of the prostate. Am J Surg (1976) 0.77
Malignancy associated with antinuclear antibodies. Lancet (1972) 0.77
Re: Circulating prostate specific antigen-positive cells correlate with metastatic prostate cancer. Br J Urol (1993) 0.76
Cryosurgery of the monkey (macaque) prostate. I. Humoral immunologic responsiveness following cryostimulation. Cryobiology (1976) 0.76
Migration-inhibitory effect of serum from patients with prostatic cancer. Oncology (1974) 0.76
Prostate-specific antigen: chronology of its identification. Oncology (Williston Park) (1998) 0.76
On the identification and characterization of prostate-specific antigen. Hum Pathol (1993) 0.76
Serum immunoglobulin E in pemphigus. J Invest Dermatol (1978) 0.76
Serum antibody in patients with prostatic cancer. Br J Urol (1976) 0.76
Soluble Fc gamma receptors and the maternal-fetal response. J Leukoc Biol (1994) 0.75
Biphasic effect of cryosurgery of the prostate on lymphocyte proliferation. Cryobiology (1977) 0.75
Pemphigus-like antigens and antibodies in benign and malignant neoplasms. Arch Dermatol Res (1983) 0.75
Cryosensitivity. Factors influencing development of immunologic response following cyrosurgery of prostate. Urology (1975) 0.75
The identification of prostate-specific antigen. J Clin Lab Anal (1991) 0.75
Justice versus equity for haemophiliacs with AIDS. BMJ (1990) 0.75
Immunologic dysfunction in patients with hemophilia. Can Med Assoc J (1984) 0.75
Cryoimmunotherapy: continuing studies toward determining a rational approach for assessing the candidacy of the prostatic cancer patient for cryoimmunotherapy and postoperative responsiveness. An interim report. Cryobiology (1980) 0.75
What of the clinical significance of the cryoimmune response? Dermatol Surg (1997) 0.75
Prostaglandin E2 affects the tumor immune response in prostatic carcinoma. J Urol (1982) 0.75
Possible implications of antisperm antibodies beyond infertility. Urology (1991) 0.75
Detection of human immunodeficiency virus in blood or semen by polymerase chain reaction--reliable. Fertil Steril (1993) 0.75
The use of cryosurgery for breast cancer. Arch Surg (1998) 0.75
The identification of prostate-specific antigen. Am J Clin Pathol (1991) 0.75
Treatment of recurrent spontaneous abortion: immunization with seminal plasma trophoblast-lymphocyte crossreacting antigen. Am J Reprod Immunol (1989) 0.75
Prostatic acid phosphatase. Br Med J (1971) 0.75
The female prostate. J Natl Cancer Inst (1998) 0.75
Pathogenesis of AIDS in hemophilia. Ann Allergy (1990) 0.75
Re: Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation. J Urol (1998) 0.75
Antibodies in malignant disease. Br Med J (1972) 0.75